193 related articles for article (PubMed ID: 36285487)
1. Phosphatase-independent role of phosphatase of regenerating liver in cancer progression.
Funato Y; Hashizume O; Miki H
Cancer Sci; 2023 Jan; 114(1):25-33. PubMed ID: 36285487
[TBL] [Abstract][Full Text] [Related]
2. Burst kinetics and CNNM binding are evolutionarily conserved properties of phosphatases of regenerating liver.
Fakih R; Goldstein RH; Kozlov G; Gehring K
J Biol Chem; 2023 Apr; 299(4):103055. PubMed ID: 36822330
[TBL] [Abstract][Full Text] [Related]
3. The double lives of phosphatases of regenerating liver: A structural view of their catalytic and noncatalytic activities.
Gehring K; Kozlov G; Yang M; Fakih R
J Biol Chem; 2022 Jan; 298(1):101471. PubMed ID: 34890645
[TBL] [Abstract][Full Text] [Related]
4. Structural Basis of the Oncogenic Interaction of Phosphatase PRL-1 with the Magnesium Transporter CNNM2.
Giménez-Mascarell P; Oyenarte I; Hardy S; Breiderhoff T; Stuiver M; Kostantin E; Diercks T; Pey AL; Ereño-Orbea J; Martínez-Chantar ML; Khalaf-Nazzal R; Claverie-Martin F; Müller D; Tremblay ML; Martínez-Cruz LA
J Biol Chem; 2017 Jan; 292(3):786-801. PubMed ID: 27899452
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of phosphatase of regenerating liver gene family in non-small cell lung cancer.
Hwang JJ; Min SH; Sin KH; Heo YS; Kim KD; Yoo OJ; Lee SH
Oncol Rep; 2012 Feb; 27(2):535-40. PubMed ID: 21993571
[TBL] [Abstract][Full Text] [Related]
6. Phosphatase of Regenerating Liver-1 Regulates Wing Vein Formation through TGF-β Pathway in
Zheng H; Lou Z; Yuan X; Wu H; Yang X; Xi Y
Front Biosci (Landmark Ed); 2022 Jun; 27(6):176. PubMed ID: 35748252
[TBL] [Abstract][Full Text] [Related]
7. Targeting phosphatases of regenerating liver (PRLs) in cancer.
Wei M; Korotkov KV; Blackburn JS
Pharmacol Ther; 2018 Oct; 190():128-138. PubMed ID: 29859177
[TBL] [Abstract][Full Text] [Related]
8. Phosphatase of regenerating liver-3 localizes to cyto-membrane and is required for B16F1 melanoma cell metastasis in vitro and in vivo.
Song R; Qian F; Li YP; Sheng X; Cao SX; Xu Q
PLoS One; 2009; 4(2):e4450. PubMed ID: 19214221
[TBL] [Abstract][Full Text] [Related]
9. PRL PTPs: mediators and markers of cancer progression.
Bessette DC; Qiu D; Pallen CJ
Cancer Metastasis Rev; 2008 Jun; 27(2):231-52. PubMed ID: 18224294
[TBL] [Abstract][Full Text] [Related]
10. Targeting PRL phosphatases in hematological malignancies.
Xiao S; Chen H; Bai Y; Zhang ZY; Liu Y
Expert Opin Ther Targets; 2024 Apr; 28(4):259-271. PubMed ID: 38653737
[TBL] [Abstract][Full Text] [Related]
11. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
[TBL] [Abstract][Full Text] [Related]
12. The Tyrosine Phosphatase PRL Regulates Attachment of Toxoplasma gondii to Host Cells and Is Essential for Virulence.
Yang C; Blakely WJ; Arrizabalaga G
mSphere; 2022 Jun; 7(3):e0005222. PubMed ID: 35603560
[TBL] [Abstract][Full Text] [Related]
13. PRL3 pseudophosphatase activity is necessary and sufficient to promote metastatic growth.
Kozlov G; Funato Y; Chen YS; Zhang Z; Illes K; Miki H; Gehring K
J Biol Chem; 2020 Aug; 295(33):11682-11692. PubMed ID: 32571875
[TBL] [Abstract][Full Text] [Related]
14. Phosphocysteine in the PRL-CNNM pathway mediates magnesium homeostasis.
Gulerez I; Funato Y; Wu H; Yang M; Kozlov G; Miki H; Gehring K
EMBO Rep; 2016 Dec; 17(12):1890-1900. PubMed ID: 27856537
[TBL] [Abstract][Full Text] [Related]
15. Phosphatase of regenerating liver-1 promotes cell migration and invasion and regulates filamentous actin dynamics.
Nakashima M; Lazo JS
J Pharmacol Exp Ther; 2010 Aug; 334(2):627-33. PubMed ID: 20484558
[TBL] [Abstract][Full Text] [Related]
16. The Oncogenic PRL Protein Causes Acid Addiction of Cells by Stimulating Lysosomal Exocytosis.
Funato Y; Yoshida A; Hirata Y; Hashizume O; Yamazaki D; Miki H
Dev Cell; 2020 Nov; 55(4):387-397.e8. PubMed ID: 32918875
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice.
Guo K; Tang JP; Tan CP; Wang H; Zeng Q
Cancer Biol Ther; 2008 May; 7(5):750-7. PubMed ID: 18364570
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the protein tyrosine phosphatase PRL from Entamoeba histolytica.
Ramírez-Tapia AL; Baylón-Pacheco L; Espíritu-Gordillo P; Rosales-Encina JL
Exp Parasitol; 2015 Dec; 159():168-82. PubMed ID: 26431820
[TBL] [Abstract][Full Text] [Related]
19. Molecular function and biological importance of CNNM family Mg2+ transporters.
Funato Y; Miki H
J Biochem; 2019 Mar; 165(3):219-225. PubMed ID: 30476181
[TBL] [Abstract][Full Text] [Related]
20. PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3.
Zhang H; Kozlov G; Li X; Wu H; Gulerez I; Gehring K
Sci Rep; 2017 Mar; 7(1):48. PubMed ID: 28246390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]